Category: All News

Company logo of ApoRisk GmbH
ApoRisk GmbH

Eli Lilly's Abnehmspritze: Ein potenzieller Sprengsatz für das deutsche Gesundheitssystem

Der weltweit führende Pharmakonzern Eli Lilly hat angekündigt, in Deutschland bald Fettweg-Spritzen herzustellen, was eine bedeutende Investition in Höhe von Milliarden von Euro darstellt. Die Einführung dieser Injektionen zur Gewichtsabnahme verspricht eine neue Ära im Bereich der Adipositasbehandlung einzuläuten. Allerdings hegen einige Experten Bedenken darüber, dass dieses Vorhaben massive Kosten für das deutsche Gesundheitssystem mit sich bringen könnte.

read more on aporisk.de

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.